3187eP Higher frequency of immune-related adverse events with ICIs in the adjuvant vs metastatic setting. - Boulouta, A.; Kyriazoglou, A.; Economopoulou, P.; Kotsantis, I.; Kontou, P.I.; Bagos, P.G.; Psyrri, A. (Annals of Oncology, 2025)